CUPERTINO, Calif., July 5, 2022 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical corporation targeted on epigenetic regulation to create solutions for acute organ damage and continual liver illnesses, currently declared the appointment of Timothy M. Papp as its Main Economical Officer. In this new purpose, Mr. Papp will immediate and oversee all fiscal […]
Trending Tags
Monday, Nov 18, 2024